BlackRock’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.9M | Buy |
|
|||||
|
2025
Q1 | $40M | Sell |
|
|||||
|
2024
Q4 | $34.8M | Buy |
|
|||||
|
2024
Q3 | $44.1M | Buy |
|
|||||
|
2024
Q2 | $72.2M | Buy |
|
|||||
|
2024
Q1 | $55.7M | Sell |
|
|||||
|
2023
Q4 | $53.8M | Sell |
|
|||||
|
2023
Q3 | $18.3M | Buy |
|
|||||
|
2023
Q2 | $26.4M | Buy |
|
|||||
|
2023
Q1 | $12.7M | Sell |
|
|||||
|
2022
Q4 | $35.6M | Buy |
|
|||||
|
2022
Q3 | $30.9M | Buy |
|
|||||
|
2022
Q2 | $22M | Buy |
|
|||||
|
2022
Q1 | $28.7M | Sell |
|
|||||
|
2021
Q4 | $32.5M | Sell |
|
|||||
|
2021
Q3 | $54.1M | Buy |
|
|||||
|
2021
Q2 | $75.3M | Buy |
|
|||||
|
2021
Q1 | $84.4M | Buy |
|
|||||
|
2020
Q4 | $44M | Buy |
|
|||||
|
2020
Q3 | $14.6M | Buy |
|
|||||
|
2020
Q2 | $25.2M | Buy |
|
|||||
|
2020
Q1 | $1.95M | Sell |
|
|||||
|
2019
Q4 | $2.58M | Buy |
|
|||||
|
2019
Q3 | $440K | Sell |
|
|||||
|
2019
Q2 | $371K | Sell |
|
|||||
|
2019
Q1 | $2.7M | Sell |
|
|||||
|
2018
Q4 | $2.02M | Sell |
|
|||||
|
2018
Q3 | $9.48M | Buy |
|
|||||
|
2018
Q2 | $7.8M | Sell |
|
|||||
|
2018
Q1 | $10.1M | Sell |
|
|||||
|
2017
Q4 | $12.2M | Sell |
|
|||||
|
2017
Q3 | $15.3M | Buy |
|
|||||
|
2017
Q2 | $20.9M | Buy |
|
|||||
|
2017
Q1 | $7.36M | Buy |
|
|||||
|
2016
Q4 | $14K | Hold |
|
|||||
|
2016
Q3 | $19K | Hold |
|
|||||
|
2016
Q2 | $15K | Buy |
|
|||||
|
2016
Q1 | $1K | Buy |
|